Thank you for your interest
Listen to the Podcast below or view a Transcript of the Podcast here
Parker Institute for Cancer Immunotherapy -Tumor Neoantigen Selection Alliance (TESLA)
Danny Wells, Ph.D., Scientist, Informatics, Parker Institute for Cancer Immunotherapy
Danny Wells speaks to CHI on July 6th, 2017. Dr. Wells will be speaking during Neoantigen-Based Personalized Immunotherapies meeting at ImPACT: Immunotherapy Progress and Clinical Treatments, December 5-7th, 2018 in San Diego, California.
Topics Include: scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy.
For more information, please visit www.ImpactImmunotherapy.com/Neoantigen-Immunotherapy/